4th Quarter - Report

AMERICAN OSTEOPATHIC ASSOCIATION for AMERICAN OSTEOPATHIC ASSOCIATION

Firm
Client
Income
—
Expenses
$124,148
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

National Health Service Corp; Community Health Centers; Health Resource & Services Administration

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Government Accountability Office (GAO); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); White House Office; Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ); SENATE; Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Insurance INS

Professional Liability Insurance; Health Insurance

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Executive Office of the President (EOP); Food & Drug Administration (FDA); Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); White House Office; Medicare Payment Advisory Commission (MedPAC); SENATE; Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS)

Taxation/Internal Revenue Code TAX

COVID-19 response and physician support; Primary Care Enhancement Act

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ); Medicare Payment Advisory Commission (MedPAC); Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); White House Office; Government Accountability Office (GAO); SENATE

Health Issues HCR

Medicare Physician Payment Reform; Physician Workforce

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Food & Drug Administration (FDA); SENATE; Executive Office of the President (EOP); Medicare Payment Advisory Commission (MedPAC); Government Accountability Office (GAO); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); White House Office; Centers For Disease Control & Prevention (CDC)

Medicare/Medicaid MMM

Graduate Medical Education; Resident Physician Shortage Act

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Government Accountability Office (GAO); White House Office; Executive Office of the President (EOP); Medicare Payment Advisory Commission (MedPAC); Office of Management & Budget (OMB); SENATE

Education EDU

Teaching Health Center Graduate Medical Education; National Health Service Corps; Foreign Medical School Accountability Fairness Act

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. VP Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); Medicare Payment Advisory Commission (MedPAC); Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); White House Office; Food & Drug Administration (FDA)

Medical/Disease Research/Clinical Labs MED

NIH, FDA

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Government Accountability Office (GAO); Food & Drug Administration (FDA); White House Office; Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA); SENATE

Torts TOR

No Surprises Act

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Executive Office of the President (EOP); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); SENATE; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); White House Office; Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); Government Accountability Office (GAO)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.